Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $1.319B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | 2,179,735 | $132M | 10.0% | — | — | COM | 462222100 |
| — | SPRINGWORKS THERAPEUTICS INC | 3,079,155 | $119M | 9.0% | — | — | COM | 85205L107 |
| ACIU | AC IMMUNE SA | 11,342,505 | $96.64M | 7.3% | — | — | SHS | H00263105 |
| — | PRINCIPIA BIOPHARMA INC | 1,716,734 | $94.04M | 7.1% | — | — | COM | 74257L108 |
| CYTK | CYTOKINETICS INC | 7,206,458 | $76.46M | 5.8% | — | — | COM | 23282W605 |
| XOMA | XOMA CORP DEL | 2,642,405 | $72.14M | 5.5% | — | — | COM NEW | 98419J206 |
| — | ARQULE INC | 2,978,683 | $59.45M | 4.5% | — | — | COM | 04269E107 |
| — | CALITHERA BIOSCIENCES INC | 9,559,642 | $54.59M | 4.1% | — | — | COM | 13089P101 |
| — | MOLECULAR TEMPLATES INC | 3,358,332 | $46.97M | 3.6% | — | — | COM | 608550109 |
| — | MERUS N V | 3,169,654 | $44.63M | 3.4% | — | — | COM | N5749R100 |
| — | GLYCOMIMETICS INC | 7,361,801 | $38.94M | 3.0% | — | — | COM | 38000Q102 |
| RCUS | ARCUS BIOSCIENCES INC | 3,579,023 | $36.15M | 2.7% | — | — | COM | 03969F109 |
| — | FIVE PRIME THERAPEUTICS INC | 7,783,001 | $35.72M | 2.7% | — | — | COM | 33830X104 |
| REPL | REPLIMUNE GROUP INC | 2,309,109 | $33.14M | 2.5% | — | — | COM | 76029N106 |
| KURA | KURA ONCOLOGY INC | 1,998,276 | $27.48M | 2.1% | — | — | COM | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 1,949,075 | $25.55M | 1.9% | — | — | COM | 98420N105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 785,851 | $24.47M | 1.9% | — | — | COM | 71722W107 |
| — | PIERIS PHARMACEUTICALS INC | 5,349,905 | $19.37M | 1.5% | — | — | COM | 720795103 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $16.73M | 1.3% | — | — | COM | 45665G303 |
| IMVT | IMMUNOVANT INC | 999,996 | $15.85M | 1.2% | — | — | COM | 45258J102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,764,784 | $15.49M | 1.2% | — | — | COM | 87164F105 |
| ANAB | ANAPTYSBIO INC | 939,565 | $15.27M | 1.2% | — | — | COM | 032724106 |
| — | BLUEPRINT MEDICINES CORP | 183,834 | $14.73M | 1.1% | — | — | COM | 09627Y109 |
| — | ESSA PHARMA INC | 2,640,565 | $14.52M | 1.1% | — | — | COM | 29668H708 |
| — | MEI PHARMA INC | 5,346,272 | $13.26M | 1.0% | — | — | COM NEW | 55279B202 |
| — | X4 PHARMACEUTICALS INC | 1,141,974 | $12.22M | 0.9% | — | — | COM | 98420X103 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $10.95M | 0.8% | — | — | COM | 12648L601 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,436,429 | $10.77M | 0.8% | — | — | COM | 45166A102 |
| — | GALMED PHARMACEUTICALS LTD | 1,832,484 | $10.59M | 0.8% | — | — | SHS | M47238106 |
| — | PREVAIL THERAPEUTICS INC | 656,483 | $10.39M | 0.8% | — | — | COM | 74140Y101 |
| — | CIDARA THERAPEUTICS INC | 2,687,738 | $10.32M | 0.8% | — | — | COM | 171757107 |
| — | AKERO THERAPEUTICS INC | 451,009 | $10.01M | 0.8% | — | — | COM | 00973Y108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,627,568 | $8.854M | 0.7% | — | — | COM | 221015100 |
| — | VERASTEM INC | 6,328,994 | $8.481M | 0.6% | — | — | COM | 92337C104 |
| SPRO | SPERO THERAPEUTICS INC | 845,405 | $8.129M | 0.6% | — | — | COM | 84833T103 |
| — | SELECTA BIOSCIENCES INC | 3,284,072 | $7.816M | 0.6% | — | — | COM | 816212104 |
| — | MERSANA THERAPEUTICS INC | 1,180,553 | $6.765M | 0.5% | — | — | COM | 59045L106 |
| CTMX | CYTOMX THERAPEUTICS INC | 766,148 | $6.367M | 0.5% | — | — | COM | 23284F105 |
| — | FORWARD PHARMA A/S | 925,724 | $6.008M | 0.5% | — | — | SPONSORED ADR | 34986J105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 682,630 | $4.813M | 0.4% | — | — | COM | 74366E102 |
| — | ERYTECH PHARMA | 625,000 | $4.55M | 0.3% | — | — | SPONSORED ADR | 29604W108 |
| — | ALPINE IMMUNE SCIENCES INC | 1,137,764 | $4.369M | 0.3% | — | — | COM | 02083G100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 2,100,305 | $4.348M | 0.3% | — | — | COM NEW | 372427401 |
| — | GAMIDA CELL LTD | 1,000,000 | $4.3M | 0.3% | — | — | SHS | M47364100 |
| ARGX | ARGENX SE | 25,000 | $4.013M | 0.3% | — | — | SPONSORED ADR | 04016X101 |
| — | BIOLINERX LTD | 1,733,036 | $3.899M | 0.3% | — | — | SPONSORED ADR | 09071M205 |
| — | SUTRO BIOPHARMA INC | 345,196 | $3.797M | 0.3% | — | — | COM | 869367102 |
| OVID | OVID THERAPEUTICS INC | 734,301 | $3.047M | 0.2% | — | — | COM | 690469101 |
| — | EIGER BIOPHARMACEUTICALS INC | 143,567 | $2.139M | 0.2% | — | — | COM | 28249U105 |
| — | SUNESIS PHARMACEUTICALS INC | 6,194,925 | $2.092M | 0.2% | — | — | COM | 867328700 |
| — | SURFACE ONCOLOGY INC | 1,086,251 | $2.042M | 0.2% | — | — | COM | 86877M209 |
| — | REGULUS THERAPEUTICS INC | 2,035,695 | $1.812M | 0.1% | — | — | COM NEW | 75915K200 |
| — | SPRING BK PHARMACEUTICALS INC | 951,701 | $1.504M | 0.1% | — | — | COM | 849431101 |
| — | CONTRAFECT CORP | 1,898,990 | $1.179M | 0.1% | — | — | COM | 212326102 |
| — | BRICKELL BIOTECH INC | 442,788 | $664K | 0.1% | — | — | COM | 10802T105 |
| — | NOVUS THERAPEUTICS INC | 828,876 | $481K | 0.0% | — | — | COM | 67011N105 |
| — | KEZAR LIFE SCIENCES INC | 116,712 | $468K | 0.0% | — | — | COM | 49372L100 |